CHAI 2021 HIV market report: the state of the HIV market in low- and middle-income countries
On 12 October 2021, CHAI release the 12th issue of their annual HIV market report.
The report reviews a global perspective on the complex, changing markets for HIV medicines in low- and middle-income countries.
All aspects of the global HIV response have had important updates over the past year.
- The rollout of a generic, affordable paediatric formulation of dolutegravir.
- Exciting clinical trial results set to change how cryptococcal meningitis is treated.
- Further advances in long-acting drugs for HIV prevention.
- Pricing deals that continue to make HIV self-testing more affordable.
An excellent 60-minute webinar review of the many changes to global HIV health is also available online:
CHAI. 2021 HIV market report (12th edition).